Waiver of Subsequent Equity Sales Provision Sample Contracts

WAIVER OF SUBSEQUENT EQUITY SALES PROVISION

Waiver of Subsequent Equity Sales Provision • October 31st, 2024 • Applied Dna Sciences Inc • Services-testing laboratories

• Contract Type
  Waiver of Subsequent Equity Sales Provision
• Filed
  October 31st, 2024
• Company
  Applied Dna Sciences Inc
• Industry
  Services-testing laboratories

Reference is hereby made to Section 4(p) of that certain Placement Agency Agreement (the “Placement Agency Agreement”), dated May 28, 2024, by and among Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), Craig-Hallum Capital Group LLC (“Craig-Hallum”) and Laidlaw & Company (UK) Ltd. Capitalized terms used but not otherwise defined herein have the meanings set forth in the Placement Agency Agreement.